EUVIMEDEUVIMED entdecken
Crossref

Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma

Danai Samutpradit, Phurin Areesawangkit, Pranaidej Hengswat, Wannasiri Chiraphapphaiboon, Ployploen Phikulsod, Kornkan Choome, Nattaporn Phanthaphol, Yupanun Wutti-In, Mutita Junking, Sanya Sukpanichnant, Thaweesak Chieochansin, Pa-Thai Yenchitsomanus

Anticancer Research · 2026

DOI: 10.21873/anticanres.17939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Danai Samutpradit und 11 weiteren Autor:innen. Beteiligte Einrichtung: Siriraj Center of Research Excellence for Cancer Immunotherapy and Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj H…. Hauptthemen laut MEDLINE: Multiple Myeloma, Dendritic Cells, Membrane Proteins, T-Lymphocytes, Cytotoxic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaDendritic CellsMembrane ProteinsT-Lymphocytes, CytotoxicAntigens, NeoplasmHumansCell DifferentiationMaleFemaleCell Line, TumorMiddle AgedAgedImmunotherapyLymphocyte ActivationInterferon-gamma

Stichwörter der Autor:innen

NY-ESO-1SD-DCSelf-differentiated dendritic cellsadoptive T cell therapymultiple myeloma

Substanzen

Membrane ProteinsCTAG1B protein, humanAntigens, NeoplasmInterferon-gamma

Autor:innen und Institutionen

  • Siriraj Center of Research Excellence for Cancer Immunotherapy and Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Siriraj Center of Research Excellence for Cancer Immunotherapy and Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; thaweesak.chieochansin…
  • Computational and Genomic Hematology Group (GrHeCo-Xen), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Siriraj Center of Research Excellence for Cancer Immunotherapy and Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; pathai.yen@mahidol.edu.

Zitieren

APA

Samutpradit, D., Areesawangkit, P., Hengswat, P., Chiraphapphaiboon, W., Phikulsod, P., Choome, K., Phanthaphol, N., Wutti-In, Y., Junking, M., Sukpanichnant, S., Chieochansin, T., & Yenchitsomanus, P. T. (2026). Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma. Anticancer Research. https://doi.org/10.21873/anticanres.17939

Vancouver

Samutpradit D, Areesawangkit P, Hengswat P, Chiraphapphaiboon W, Phikulsod P, Choome K, et al. Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma. Anticancer Research. 2026. doi:10.21873/anticanres.17939

BibTeX
@article{Samutpradit2026,
  author = {Samutpradit, Danai and Areesawangkit, Phurin and Hengswat, Pranaidej and Chiraphapphaiboon, Wannasiri and Phikulsod, Ployploen and Choome, Kornkan and Phanthaphol, Nattaporn and Wutti-In, Yupanun and Junking, Mutita and Sukpanichnant, Sanya and Chieochansin, Thaweesak and Yenchitsomanus, Pa-Thai},
  title = {Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.17939}
}
Kostenlos starten →